rss
J Med Ethics 2002;28:170-172 doi:10.1136/jme.28.3.170
  • Clinical ethics

Neuromuscular blockers—a means of palliation?

  1. L Hawryluck
  1. Correspondence to:
 Dr L Hawryluck, Ian Anderson Continuing Education Program in End of Life Care, University Health Network, University of Toronto, Canada;
 laura.hawryluck{at}utoronto.ca
  • Accepted 18 January 2002
  • Revised 17 January 2002

Abstract

As we die, our respiratory pattern is altered and we seem to gasp and struggle for each breath. Such gasping is commonly seen as a clear sign of dyspnoea and suffering by families and loved ones, however, it is unclear whether it is perceived at all by the dying person. Narcotics and sedatives do not seem to affect these gasping respirations. In this issue of the Journal of Medical Ethics, we are asked to consider whether the last gasp of a dying patient could be or, perhaps, even should be avoided by administering neuromuscular blockers to palliate dying patients. For many reasons, such as our current failure to alleviate pain and distress, stories of inadequate analgesia and sedation in critically ill paralysed patients and the inability to know the intent—whether to palliate or to euthanise—it would seem that administering neuromuscular blockers should not be ethically permissible.

Footnotes

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.